Fairchem Organics Ltd Stock Hits 52-Week Low Amid Continued Downtrend

Feb 24 2026 11:30 AM IST
share
Share Via
Fairchem Organics Ltd’s share price declined to a fresh 52-week low of Rs.576.6 today, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has now recorded losses over four consecutive sessions, cumulatively falling by 5.82% during this period, reflecting persistent pressures within the specialty chemicals sector and company-specific performance factors.
Fairchem Organics Ltd Stock Hits 52-Week Low Amid Continued Downtrend

Recent Price Movement and Market Context

On 24 Feb 2026, Fairchem Organics Ltd’s stock closed at Rs.576.6, underperforming its own historical levels and trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning indicates sustained bearish momentum. Despite the stock outperforming its sector by 0.64% on the day, the broader market environment remains challenging. The Sensex opened lower by 242.12 points and closed down 488.48 points at 82,564.06, a decline of 0.88%. The benchmark index remains 4.35% below its 52-week high of 86,159.02, with the 50-day moving average currently below the 200-day moving average, signalling a cautious market sentiment.

Long-Term Performance and Valuation Metrics

Over the past year, Fairchem Organics Ltd has delivered a negative return of 39.30%, significantly lagging behind the Sensex’s positive 10.89% gain over the same period. The stock’s 52-week high was Rs.1100, highlighting the extent of the decline. The company’s market capitalisation grade stands at 4, reflecting its mid-tier market cap status within the specialty chemicals sector.

Financially, the company has faced headwinds with operating profit shrinking at an annualised rate of 33.06% over the last five years. The latest six months’ profit after tax (PAT) was reported at Rs.1.55 crore, representing a steep decline of 79.42%. Quarterly net sales have also reached a low of Rs.100.13 crore, underscoring subdued revenue generation. Return on capital employed (ROCE) for the half-year period is at a modest 3.47%, indicating limited efficiency in capital utilisation.

This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.

  • - Target price included
  • - Early movement detected
  • - Complete analysis ready

Get Complete Analysis Now →

Stock Ratings and Quality Assessment

MarketsMOJO assigns Fairchem Organics Ltd a Mojo Score of 26.0, categorising it as a Strong Sell. This rating was upgraded from Sell to Strong Sell on 17 Feb 2026, reflecting deteriorating fundamentals and weak financial performance. The company’s consistent negative results over the last six quarters have contributed to this assessment. Additionally, the stock has underperformed the BSE500 index across multiple time frames, including the last three years, one year, and three months, indicating persistent challenges in maintaining competitive performance.

Debt and Valuation Considerations

Despite the negative earnings trend, Fairchem Organics Ltd maintains a relatively strong debt servicing capacity, with a low Debt to EBITDA ratio of 1.11 times. This suggests manageable leverage levels in relation to earnings before interest, taxes, depreciation, and amortisation. The company’s enterprise value to capital employed ratio stands at 2.3, which, combined with a ROCE of 3.1%, points to a fair valuation relative to its capital base. The stock currently trades at a discount compared to the average historical valuations of its peers within the specialty chemicals sector.

Profitability and Returns Analysis

Profitability metrics have shown marked deterioration, with profits falling by 90% over the past year. This decline has been a significant factor in the stock’s underperformance. The company’s ability to generate returns on capital has been limited, as evidenced by the low ROCE figures. These financial indicators highlight the challenges faced by Fairchem Organics Ltd in sustaining growth and profitability in a competitive industry environment.

Fairchem Organics Ltd or something better? Our SwitchER feature analyzes this micro-cap Specialty Chemicals stock and recommends superior alternatives based on fundamentals, momentum, and value!

  • - SwitchER analysis complete
  • - Superior alternatives found
  • - Multi-parameter evaluation

See Smarter Alternatives →

Summary of Key Performance Indicators

To summarise, Fairchem Organics Ltd’s stock has reached a new 52-week low of Rs.576.6, reflecting a sustained period of decline. The company’s financial results have been subdued, with negative PAT growth, low ROCE, and declining net sales. While the company maintains a manageable debt profile and trades at a valuation discount relative to peers, its long-term growth trajectory has been weak, as demonstrated by the annualised contraction in operating profit and consistent negative quarterly results.

Market and Sector Positioning

Operating within the specialty chemicals sector, Fairchem Organics Ltd faces competitive pressures and market dynamics that have contributed to its recent performance. The stock’s underperformance relative to the Sensex and BSE500 indices highlights the challenges in delivering shareholder value amid these conditions. The broader market’s cautious tone, as indicated by the Sensex’s recent declines and technical indicators, further contextualises the stock’s movement.

Technical Indicators and Trading Patterns

The stock’s position below all major moving averages signals a bearish technical outlook. The four-day consecutive decline and the 5.82% loss over this period reinforce the downward momentum. Such technical factors often influence trading behaviour and reflect investor sentiment towards the company’s near-term prospects.

Conclusion

Fairchem Organics Ltd’s stock performance, culminating in a 52-week low of Rs.576.6, is the result of a combination of subdued financial results, weak profitability metrics, and challenging market conditions. The company’s strong debt servicing ability and valuation discount provide some balance to the overall picture, but the persistent negative earnings and underperformance relative to benchmarks remain key considerations in understanding the stock’s current position.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News